![[Correspondence] Pragmatic antipsychotics trial—caution in interpretation](https://d3typ5yqytip29.cloudfront.net/article/psychological-therapy-DTJ82H8.jpg?format=webp&width=780)
Erik Johnsen and colleagues1 recently published a semi-randomised, rater-blind trial (BeSt InTro) that applied a pragmatic design to resemble clinical practice as much as possible. The authors report that amisulpride was more efficacious than aripiprazole or olanzapine in reducing total scores on the Positive And Negative Syndrome Scale in adults with schizophrenia-spectrum disorders and that the three drugs did not differ regarding side-effects.
Like
Save
Share